Rhelixa, Inc., Japan

Time frame: 1 December 2022 - 30 November 2023

Profile

The positions in the table below reflect the Rhelixa, Inc.'s position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the corresponding table where Rhelixa, Inc. is listed.

Position by research output Share

Global Japan
Overall 7197 473
Corporate 1197 109

Position by research output Share in subject areas

Global Japan
Biological sciences 3629 263

Research

Overall research output

Count Share
Overall 1 0.03

Overall Count and Share for 'Rhelixa, Inc.' based on the 12-month time frame mentioned above.

View all articles

Research outputs by subject area

Subject Count Share
Biological sciences 1 0.03

Note: Articles may be assigned to more than one subject area. Hover over the donut graph to view the Share for each subject.

Share output for the past 5 years

Compare with other institutions

Nature Strategy Reports

Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports.

  1. Actionable insights into research performance.

  2. Detailed analysis of strengths and weaknesses.

  3. Covers all major disciplines and regions of the world.

Nature Navigator

Data-driven insights for informed research strategy decisions with AI summarisation technology.

  1. Track trends, summarise articles effortlessly.

  2. Spark serendipitous discoveries.

  3. Uncover collaboration opportunities.

Collaboration

International vs domestic collaboration by Share

Type Percentage
International (1 institutions) 3.9%
Domestic (11 institutions) 96.1%

Note: Hover over the graph to view the percentage of collaboration.

Top 5 domestic collaborators with Rhelixa, Inc. by Share

Collaborating institutions

Share

Top 5 international collaborators with Rhelixa, Inc. by Share

Collaborating institutions

Share

  • Advertisement

Latest supplement

Nature Index 2024 Health Sciences

More money is being spent on medical R&D than ever before, but with few new drugs to show for it. The race is on to find technological solutions that will speed up drug development and deliver better clinical outcomes. Nature Index Health Sciences 2024 highlights the people and projects that are bringing fresh perspectives to some of the most complex challenges in medicine and provides an in-depth look at how one country – the United States – is dominating the field.

Nature Index 2024 Health Sciences